Skip to content
MarketScale
‹ Back to IndustriesSciences

What AI Means for Future Scientists

It is a cry that has been repeated for centuries now— ‘technology will take my job.’ This is a sentiment that is certainly not to be taken lightly. History shows that technology does indeed change the nature of work. Perhaps the most dramatic example of this was the industrial revolution during the late 18th and…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Samuel Miller · AiArtificial IntelligenceAutomationHuman Jobs
Share
What AI Means for Future Scientists

Key takeaways

01

It is a cry that has been repeated for centuries now— ‘technology will take my job.’ This is a sentiment that is certainly not to be taken lightly.

02

History shows that technology does indeed change the nature of work.

03

Perhaps the most dramatic example of this was the industrial revolution during the late 18th and…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

It is a cry that has been repeated for centuries now— ‘technology will take my job.’ This is a sentiment that is certainly not to be taken lightly. History shows that technology does indeed change the nature of work. Perhaps the most dramatic example of this was the industrial revolution during the late 18th and early 19th centuries that saw Europe and America transform from agrarian states to mechanized giants powered by coal and whale oil.

A New Revolution?

Today a quieter but no less drastic shift is taking place as mobile technology, blockchain, and artificial intelligence (AI), among other digital technologies, change the nature of work for many. While a first reaction might be to worry for the safety of human jobs, it is more accurate to say that technology changes the nature of certain jobs.

For example, ATMs did not remove the job of the bank teller, it simply altered their primary role from dispensing cash, to opening accounts and other clerical tasks.

The AI Effect

Perhaps the most disruptive, and ethically vague, of these new technologies is AI. One big concern related to AI is how it will affect jobs that require advanced quantitative skills, such as those in the scientific fields. Obviously, the scientific fields encompass a great deal of jobs requiring an equally diverse set of skills and qualifications. For the purposes of this article, we are discussing jobs that require higher degree such as an MS/Ph.D, or a medical qualification such as an MD.

Beginning with the assumption that these types of jobs are more at risk of artificial intelligence automation. Jobs in scientific fields are by and large more quantitative than their counterparts in the humanities or social sciences. Quantitative work is often formulaic by nature, and therefore capable of being done by highly-intelligent computers. Certain lab processes such as component testing are already being done by machines.

However, many scientific fields also require highly specific kinds of qualitative and ethical reasoning as well. This can most easily be seen in the medical fields, where a certain amount of humanity is required to diagnose and understand medical tests.

What it Means for Science

A recent article published by a career radiologist for The Scientist magazine highlights the delicate human decisions he must make every day, decisions that, at least currently, artificial intelligence is incapable of making. He demonstrates how AI is very good at identifying the fact based “what” questions, but not the judgement based “why’s.”

These are insights based on human experience and understanding that are incredibly difficult if not impossible to program. This is the human strength of the sciences and leveraging, cultivating this advantage should become a priority for educators and institutions in the near future.

Emphasizing the human side of the sciences and making it a bigger part of the field, will help prevent AI from automating science field jobs. And it is not just the sciences; Re-discovering the humanities has been a growing movement in areas such as business as well, where fields like ethical philosophy and creative design thinking have become popular to not just avoid automation, but to inject some meaning and, well, humanity into the field. At the end of the day, machines are not human and, at least for now, there are somethings that humans are just better at.

For the latest news, videos, and podcasts in the Science Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – twitter.com/ScienceMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

SM
Samuel Miller

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

SM
Samuel Miller

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512